Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q3 EPS of ($0.33), $0.51 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• ZenaTech acquires Canadian engineering firm in its 28th DaaS deal
• Elanco Animal Health (ELAN) Reiterated at Buy by Stifel as Rebate Activity Accelerates